BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 19527139)

  • 1. Approaching clinical proteomics: current state and future fields of application in fluid proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tarnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Verhuven W; Wagener C; Wagner O; Schmitz G
    Clin Chem Lab Med; 2009; 47(6):724-44. PubMed ID: 19527139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaching clinical proteomics: current state and future fields of application in cellular proteomics.
    Apweiler R; Aslanidis C; Deufel T; Gerstner A; Hansen J; Hochstrasser D; Kellner R; Kubicek M; Lottspeich F; Maser E; Mewes HW; Meyer HE; Müllner S; Mutter W; Neumaier M; Nollau P; Nothwang HG; Ponten F; Radbruch A; Reinert K; Rothe G; Stockinger H; Tárnok A; Taussig MJ; Thiel A; Thiery J; Ueffing M; Valet G; Vandekerckhove J; Wagener C; Wagner O; Schmitz G
    Cytometry A; 2009 Oct; 75(10):816-32. PubMed ID: 19739086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preanalytical guidelines for clinical proteomics investigation of biological fluids].
    Lehmann S; Roche S; Allory Y; Barthelaix A; Beaudeux JL; Berger F; Betsou F; Borg J; Dupuy A; Garin J; Quillard M; Lizard G; Peoc'h K; Riviere M; Ducoroy P
    Ann Biol Clin (Paris); 2009; 67(6):629-39. PubMed ID: 19939766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proteomic analysis of protein profiles in some pathological stages of the human organism].
    Kossowska B; Dudka I; Gancarz R; Antonowicz-Juchniewicz J
    Postepy Hig Med Dosw (Online); 2009 Nov; 63():549-63. PubMed ID: 19940332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in proximal fluid proteomics for disease biomarker discovery.
    Teng PN; Bateman NW; Hood BL; Conrads TP
    J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative body fluid proteomics in medicine - A focus on minimal invasiveness.
    Csősz É; Kalló G; Márkus B; Deák E; Csutak A; Tőzsér J
    J Proteomics; 2017 Feb; 153():30-43. PubMed ID: 27542507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current trends in quantitative proteomics - an update.
    Li H; Han J; Pan J; Liu T; Parker CE; Borchers CH
    J Mass Spectrom; 2017 May; 52(5):319-341. PubMed ID: 28418607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of the asthmatic airway.
    Wiktorowicz JE; Jamaluddin M
    Adv Exp Med Biol; 2014; 795():221-32. PubMed ID: 24162912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of proteomics in the discovery of autism biomarkers.
    Al-Ayadhi L; Halepoto DM
    J Coll Physicians Surg Pak; 2013 Feb; 23(2):137-43. PubMed ID: 23374519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of urinary proteomics/peptidomics.
    Albalat A; Mischak H; Mullen W
    Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) in Alzheimer's disease.
    Grela A; Turek A; Piekoszewski W
    Clin Chem Lab Med; 2012 Feb; 50(8):1297-304. PubMed ID: 22868793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
    Findeisen P; Neumaier M
    Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidimensional protein identification technology for clinical proteomic analysis.
    Mauri P; Scigelova M
    Clin Chem Lab Med; 2009; 47(6):636-46. PubMed ID: 19527137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics and protein analyses of ovine and caprine body fluids: current studies and future promises.
    Mavromati J; Cash P; Restelli L; Soler L
    Curr Protein Pept Sci; 2014 Feb; 15(1):45-55. PubMed ID: 24555895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human body fluid proteome analysis.
    Hu S; Loo JA; Wong DT
    Proteomics; 2006 Dec; 6(23):6326-53. PubMed ID: 17083142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the application of proteomics in renal disease diagnosis.
    Vidal BC; Bonventre JV; I-Hong Hsu S
    Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation.
    Albalat A; Mischak H; Mullen W
    Prilozi; 2011; 32(1):13-44. PubMed ID: 21822176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry-based clinical proteomics.
    Pusch W; Flocco MT; Leung SM; Thiele H; Kostrzewa M
    Pharmacogenomics; 2003 Jul; 4(4):463-76. PubMed ID: 12831324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.